没有数据	没有数据

没有数据	没有数据

Source	SDS/MSDS Samples
Sigma-Aldrich	View & Download

Synthetic Route

More

Name	CAS

More

Articles

Peer-Reviewed Papers

Synthesis, Spectral Characterization, DNA/ Protein Binding, DNA Cleavage, Cytotoxicity, Antioxidative and Molecular Docking Studies of Cu(II)Complexes Containing Schiff Base-bpy/Phen Ligands.Berelli Anupama et al.Journal of fluorescence, 27(3), 953-965 (2017-01-18) Antifungal activity of redox-active benzaldehydes that target cellular antioxidation.Jong H Kim et al.Annals of clinical microbiology and antimicrobials, 10, 23-23 (2011-06-02) Effect of Ligand Field Strength on the Spin Crossover Behaviour in 5-X-SalEen (X=Me, Br and OMe) Based Fe(III) Complexes.Bijoy Dey et al.Chemistry, an Asian journal, 15(11), 1709-1721 (2020-04-18) Syntheses, structures and electrochemistry of copper (II) salicylaldehyde/tris (3-phenylpyrazolyl) borate complexes as models for the radical copper oxidases. Halcrow MA, et al. J. Chem. Soc., Dalton Trans., 11, 1753-1762 (1999) In-vitro evaluation studies of 7-chloro-4-aminoquinoline Schiff bases and their copper complexes as cholinesterase inhibitors.Vanessa S Zanon et al.Journal of inorganic biochemistry, 191, 183-193 (2018-12-12) Mixed ligand copper(II) complexes of 1,10-phenanthroline with tridentate phenolate/pyridyl/(benz)imidazolyl Schiff base ligands: covalent vs non-covalent DNA binding, DNA cleavage and cytotoxicity.Chandrasekaran Rajarajeswari et al.Journal of inorganic biochemistry, 140, 255-268 (2014-09-10) Nanoplatforms attached Schiff bases by condensation method; Investigation of glucose oxidase enzyme as biocatalysts.Seda Kayhan et al.Artificial cells, nanomedicine, and biotechnology, 43(4), 224-229 (2013-11-22) Spectroscopy and stereochemistry of the optically active copper (II), cobalt (II) and nickel (II) complexes with Schiff bases N,N'-(1R,2R)-(-)-1, 2-cyclohexylenebis(3-methylbenzylideneiminato) and N,N'-(1R,2R)-(-)-1,2-cyclohexylenebis(5-methylbenzylideneiminato)Szlyk E, et al. Polyhedron, 21(27), 2711-2717 (2002)

Remarks